Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.

ABSTRACT:

SUBMITTER: West African Network for Clinical Trials of Antimalarial Drugs (WANECAM) 

PROVIDER: S-EPMC5889791 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature